New Zealand markets open in 4 minutes

BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
21.96-0.01 (-0.05%)
At close: 04:00PM EDT
21.96 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.01B
Enterprise value 1.01B
Trailing P/E N/A
Forward P/E 250.00
PEG ratio (5-yr expected) 63.20
Price/sales (ttm)7.09
Price/book (mrq)3.03
Enterprise value/revenue 7.33
Enterprise value/EBITDA -36.02

Trading information

Stock price history

Beta (5Y monthly) 1.69
52-week change 3-1.21%
S&P500 52-week change 326.49%
52-week high 324.50
52-week low 38.92
50-day moving average 317.91
200-day moving average 315.23

Share statistics

Avg vol (3-month) 3427.69k
Avg vol (10-day) 3587.9k
Shares outstanding 546.03M
Implied shares outstanding 646.03M
Float 835.69M
% held by insiders 13.48%
% held by institutions 198.13%
Shares short (30 Apr 2024) 43.56M
Short ratio (30 Apr 2024) 49.21
Short % of float (30 Apr 2024) 411.88%
Short % of shares outstanding (30 Apr 2024) 47.85%
Shares short (prior month 28 Mar 2024) 43.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:14
Last split date 329 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -45.84%
Operating margin (ttm)-31.17%

Management effectiveness

Return on assets (ttm)-8.04%
Return on equity (ttm)-18.20%

Income statement

Revenue (ttm)137.3M
Revenue per share (ttm)3.10
Quarterly revenue growth (yoy)-15.90%
Gross profit (ttm)N/A
EBITDA -43.15M
Net income avi to common (ttm)-62.93M
Diluted EPS (ttm)-1.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.27M
Total cash per share (mrq)0.98
Total debt (mrq)40.96M
Total debt/equity (mrq)12.29%
Current ratio (mrq)2.89
Book value per share (mrq)7.30

Cash flow statement

Operating cash flow (ttm)-14.26M
Levered free cash flow (ttm)-5.45M